Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Depreciation & Amortization (CF): 2019-2025

Historic Depreciation & Amortization (CF) for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $7,000.

  • Harmony Biosciences Holdings' Depreciation & Amortization (CF) changed negligibly% to $7,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $26,000, marking a year-over-year decrease of 93.88%. This contributed to the annual value of $267,000 for FY2024, which is 48.05% down from last year.
  • Harmony Biosciences Holdings' Depreciation & Amortization (CF) amounted to $7,000 in Q3 2025, which was up 16.67% from $6,000 recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) peaked at $164,000 during Q4 2023, and registered a low of $6,000 during Q4 2024.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $91,000 (2024), whereas its average is $72,818.
  • Over the last 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) had its largest YoY gain of 58.25% in 2024, and its largest YoY loss of 96.34% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Depreciation & Amortization (CF) (Quarterly) stood at $117,000 in 2021, then declined by 8.55% to $107,000 in 2022, then skyrocketed by 53.27% to $164,000 in 2023, then crashed by 96.34% to $6,000 in 2024, then remained steady at $7,000 in 2025.
  • Its last three reported values are $7,000 in Q3 2025, $6,000 for Q2 2025, and $7,000 during Q1 2025.